Encapsulation in an alginate–goats’ milk–inulin matrix improves survival of probiotic Bifidobacterium in simulated gastrointestinal conditions and goats’ milk yoghurt by Prasanna, Pradeep P. H. & Charalampopoulos, Dimitris
Encapsulation in an alginate–goats’ milk–
inulin matrix improves survival of probiotic  
Bifidobacterium in simulated 
gastrointestinal conditions and goats’ milk 
yoghurt 
Article 
Accepted Version 
Prasanna, P. P. H. and Charalampopoulos, D. (2019) 
Encapsulation in an alginate–goats’ milk–inulin matrix 
improves survival of probiotic Bifidobacterium in simulated 
gastrointestinal conditions and goats’ milk yoghurt. 
International Journal of Dairy Technology, 72 (1). pp. 132­141. 
ISSN 1471­0307 doi: https://doi.org/10.1111/1471­0307.12568 
Available at http://centaur.reading.ac.uk/79722/ 
It is advisable to refer to the publisher’s version if you intend to cite from the 
work.  See Guidance on citing .
To link to this article DOI: http://dx.doi.org/10.1111/1471­0307.12568 
Publisher: Wiley­Blackwell 
All outputs in CentAUR are protected by Intellectual Property Rights law, 
including copyright law. Copyright and IPR is retained by the creators or other 
copyright holders. Terms and conditions for use of this material are defined in 
the End User Agreement . 
www.reading.ac.uk/centaur 
CentAUR 
Central Archive at the University of Reading 
Reading’s research outputs online
 1 
Encapsulation in alginate-goat milk-inulin matrix improves survival of the 1 
probiotic Bifidobacterium in simulated gastrointestinal conditions and 2 
probiotic goat milk yoghurt    3 
 4 
Pradeep Prasanna a, b*, D. Charalampopoulos a 5 
a Department of Food and Nutritional Sciences, University of Reading, Whiteknights, Reading, 6 
RG6 6AP, UK 7 
b Department of Animal and Food Sciences, Faculty of Agriculture, Rajarata University of Sri 8 
Lanka, Puliyankulama, Anuradhapura, Sri Lanka 9 
 10 
Abbreviated running headline: Probiotic capsulation in goat milk-inulin matrix 11 
 12 
*Corresponding author: 13 
Pradeep Prasanna 14 
Department of Animal and Food Sciences  15 
Faculty of Agriculture  16 
Rajarata University of Sri Lanka  17 
Puliyankulama 18 
Anuradhapura 19 
Sri Lanka. 20 
Email:phpprasanna@yahoo.com 21 
 22 
 23 
 24 
 2 
Abstract 25 
In this work, a new encapsulating matrix alginate-goat milk-inulin was used to encapsulate 26 
Bifidobacterium animalis subsp. lactis BB-12. The addition of inulin resulted in capsules with 27 
compact structure and higher probiotic cell count under simulated gastrointestinal conditions 28 
and in probiotic goat milk yoghurt during refrigerated storage. Encapsulation of bacteria led to 29 
slower post-acidification yoghurts. The results of this study showed that alginate-goat milk-30 
inulin matrix has a potential to be utilised as a new encapsulation material to encapsulate 31 
probiotics to be used in goat milk-based probiotic fermented dairy products avoiding the cross-32 
contamination caused by using capsules based on cow milk.  33 
 34 
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1. Introduction 50 
Functional foods can be defined as food products which are developed using natural food 51 
additives and they are used to provide additional health benefits to the consumer exceeding the 52 
basic nutrition (Prosapio et al., 2016). The demand for functional foods is increasing around 53 
the world which is due to awareness of consumer about the relationship between consumption 54 
of functional foods and health benefits ( Fabersani et al., 2018; Martins et al., 2018; Sperry et 55 
al., 2018;). Five main sectors can be identified in relation to the functional food market namely 56 
dairy, beverage, breakfast cereals and bakery, and the dairy sector is considered as the largest 57 
functional food market around the world (Pinto et al., 2014). Most of the functional dairy 58 
products contain probiotic bacteria and these products have become popular and widely 59 
available in functional food markets (Granato et al., 2010). This specific market shows a rapid 60 
growth and there is a huge competition among producers in introducing new probiotic dairy-61 
based products (Balthazar et al., 2018; Dantas et al., 2016). 62 
 63 
Probiotics are described as “live microorganisms that, when administered in adequate amounts, 64 
confer a health benefit on the host” (Hill et al., 2014) . The most of probiotic strains have been 65 
selected and researched from the genera Bifidobacterium and Lactobacillus. Bifidobacteria are 66 
commonly used in manufacturing of fermented dairy products (Ranadheera et al., 2010). 67 
Consumption of products containing probiotic bifidobacteria has been reported to exert health 68 
benefits in relation to lowering of serum cholesterol level, enhancing immune system, 69 
alleviation of diarrhoea, reduction of lactose intolerance, modulation of gut microflora, and 70 
prevention of allergy (Prasanna et al., 2014). However, survival of probiotics in the product 71 
and inside the digestive tract depends on many factors such as acidity, culture combination, 72 
sugar concentration, temperature, and oxygen concentration in a particular product. In addition, 73 
higher acidity level in the digestive system can suppress survival of probiotic bacteria 74 
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(Ranadheera et al., 2014). Therefore, different techniques have been evaluated to enhance 75 
probiotic viability in food systems and the digestive tract, including strain selection, use of 76 
oxygen impermeable packaging systems, two-step fermentation, supplementation with 77 
micronutrients, and encapsulation; the last one is considered as the most effective (Martín et 78 
al., 2015). 79 
 80 
Prebiotics are defined as 'a substrate that is selectively utilized by host microorganisms 81 
conferring a health benefit' ( Gibson et al., 2017). Inulin is the most popular prebiotic which is 82 
commonly used in dairy products and it has been shown to enhance the viability of 83 
bifidobacteria in the large intestine (Nazzaro et al., 2012). In addition, there are some reports 84 
that prebiotics can improve the stability of alginate-based capsules containing probiotics in 85 
different food products and the digestive system (Krasaekoopt and Watcharapoka, 2014). In 86 
addition, there is a greater interest in using synbiotic which is a combination of prebiotic and 87 
probiotic in food products where prebiotics could improve survival and colonization of 88 
probiotics in the colon (Verruck et al., 2017).    89 
 90 
Encapsulation of different strains of Bifidobacterium has been used to improve their viability 91 
in various food systems and in simulated gastrointestinal conditions (Fritzen-Freire et al., 92 
2013). Sodium alginate is a common material which is used to capsulate probiotics. However, 93 
this material is very easily disintegrated at low pH leading to the release of microorganisms 94 
entrapped in beads to the environment (Krasaekoopt et al., 2004). Therefore, alginate is mixed 95 
with other materials to improve stability of alginate capsules in food systems (Etchepare et al., 96 
2016). Probiotics encapsulated in alginate-cow milk matrix were shown to improve their 97 
performances in simulated gastrointestinal conditions and in different food systems (Gbassi et 98 
al., 2009; Rajam et al., 2012; Shi et al., 2013). Milk proteins have a higher buffering capacity 99 
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and these have been shown to increase count of probiotics during digestion (Würth et al., 2015). 100 
In addition, encapsulation of probiotics in milk based materials could improve their viability 101 
in dairy foods (Ranadheera et al., 2016). In our previous study, encapsulated Bifidobacterium 102 
longum subsp. infantis CCUG 52486 in alginate-goat milk based matrix was observed to 103 
increase their survival rate in simulated gastrointestinal conditions, goat milk and cow milk 104 
(Prasanna and Charalampopoulos, 2018).  105 
 106 
Goat is considered as an important livestock species in rural areas many developing countries 107 
around the world. They can live in harsh environmental conditions where cattle cannot be 108 
reared. Therefore, goat farming is popular in many remote parts of the world where they are 109 
used for their milk, meat, and skin (Joshi et al., 2004). Dairy goats are basically used as a key 110 
food source in low income countries of the Indian subcontinent and the industry is spreading 111 
in the developed countries. The worldwide goat milk production has been doubled during the 112 
last 50 years and it is predicted to increase by 53% by 2030 (Pulina et al., 2018). Goat milk is 113 
considered as an excellent food source; it is used as raw material in producing different cheeses, 114 
ice cream and yoghurt (Milani and Wendorff, 2011). Consumption of goat milk is 115 
recommended for children and elderly people and it is also recommended as an alternative milk 116 
type for people showing allergy to cow milk (Ribeiro and Ribeiro, 2010). Goat milk is 117 
considered to have similar properties to human milk. It has the higher amount of small fat 118 
globules which are very important in human nutrition. However, goat milk produces a softer 119 
curd during the fermentation process (Clark and García, 2017). Non-bovine dairy products 120 
including goat milk are considered as excellent probiotic carriers and there is an increasing 121 
demand for such products (Ranadheera et al., 2018). 122 
 123 
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This new alginate-goat milk-inulin matrix may have an advantage that probiotics encapsulated 124 
in the new material could be directly used as an inoculum for goat milk based products ensuring 125 
minimum contamination with cow milk which is considered to cause cow milk allergy in some 126 
consumers. In this study, we report on some properties of capsules made of new alginate-goat 127 
milk-inulin matrix and survival of encapsulated probiotic B. animalis subsp. lactis BB-12 in 128 
goat milk yoghurt stored at 4 C for 28 days.  Furthermore, the capsules were evaluated under 129 
simulated gastrointestinal conditions (SGC).  130 
 131 
2. Materials and methods 132 
 Activation of microorganism 133 
B. animalis subsp. lactis BB-12 was provided by Chr. Hansen Company (Horsholm, Denmark) 134 
and the freeze-dried culture was activated using MRS broth (Oxoid, Hampshire, UK), under 135 
anaerobic condition at 37 C for 18 h, using an inoculum at the rate of 1% (w/v). The preculture 136 
was produced using two successive cultures of B. animalis subsp. lactis BB-12 where the 137 
inoculum level of was 1% (v/v). Thereafter, 200 mL of Wilkins-Chalgren (WC) anaerobe broth 138 
(Oxoid, UK) was inoculated with 1% (v/v) of the preculture and the incubation was compledted 139 
using the same conditions. The broth was centrifuged at 10,000 rpm for 10 min at 4 °C to 140 
harvest cells. At the end of the centrifugation, sterile phosphate buffered saline (PBS) (Oxoid, 141 
UK) was used to wash the pellet twice. The pellet was mixed with 10 mL of PBS to make the 142 
concentrated cell suspension.            143 
 144 
 Preparation of capsules  145 
Capsules were prepared using sterilized goat milk and sodium alginate (2%, w/v, low viscosity, 146 
Sigma-Aldrich, UK). Five treatments were prepared by mixing sodium alginate and inulin at 147 
the level of 0%, 0.5%, 1%, 1.5% and 2% (w/v) and the mixture were sterilized (121 C for 15 148 
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min). The encapsulation mixture was prepared by mixing sodium alginate mixture and 149 
sterilized goat milk at the ratio of 1.5/1 (v/v). Thereafter, each formulation was thoroughly 150 
mixed with the concentrated cell suspension at the ratio of 4/1 (v/v). The capsules were 151 
produced as described by Prasanna and Charalampopoulos (2018).   152 
 153 
 Determination of encapsulation yield and size of capsules 154 
The encapsulation yield (EY) of different matrices and size of capsules were determined as 155 
described previously (Prasanna and Charalampopoulos, 2018).  156 
 157 
 Assessment of viability of free and encapsulated bacteria 158 
Bifidobacteria selective medium (BSM) agar (Sigma-Aldrich, UK) was used to enumerate free 159 
bifidobacteria at 37 °C for 72 h under the anaerobic condition while the capsulated bacteria 160 
were enumerated as reported by Prasanna and Charalampopoulos (2018).     161 
 162 
 Viability of free and encapsulated bacterial cells during sequential incubation in SGC 163 
The method explained by Sun and Griffiths (2000) was used to prepare simulated gastric juice 164 
(SGJ), by dissolving 0.2% NaCl (w/v) in 0.08 M HCl, at pH 2 whereas simulated intestinal 165 
juice (SIJ) was prepared as described by Chávarri et al. (2010). The viability of free and 166 
encapsulated bacteria under SGC were conducted as described by Krasaekoopt et al. (2004). 167 
Glass tubes containing 9 mL of sterilized SGJ were mixed with capsules (1 g) or the free cells 168 
(1 mL). The samples were placed and incubated in a water bath at 37 C. Sampling was carried 169 
out at 0, 30, 60 and 120 min, during the incubation. The capsules were separated by filtration 170 
while free cells were separated using centrifugation (10,000 rpm for 10 min, at 4 °C). 171 
Thereafter, the free cells or the capsules were placed in glass tubes containing 9 mL of SIJ and 172 
the incubation was carried out at 37 C for 120 min. After the incubation period, the free cells 173 
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and capsules were separated as described above. The free and the capsulated bacteria were 174 
enumerated as described previously (Prasanna and Charalampopoulos, 2018).                 175 
 176 
 Preparation of probiotic goat milk yoghurt 177 
Probiotic goat milk yoghurts were produced as described by Costa et al. (2014). UHT goat 178 
milk was inoculated with thermophilic yoghurt cultures (YoFlex, YC-X11, Chr. Hansen, 179 
Hoersholm, Denmark) composed of Streptococcus thermophiles and Lactobacillus delbrueckii 180 
subsp. bulgaricus at a rate of 1% (w/v). The inoculated milk was incubated at 43 C, until the 181 
pH reached  4.5. Thereafter, 10 g of the encapsulated or 10 mL of the free cells of B. animalis 182 
subsp. lactis BB-12 was separately mixed with 100 g of goat milk yoghurt in plastic cups and 183 
the cups were stored at 4 C for 28 days. The sampling was carried out on 0, 7, 14, 21 and 28 184 
days to analyse pH and the viability of bifidobacteria. A sample (10 g) of each treatment was 185 
collected from a well-mixed yoghurt cup. The sample was mixed with 90 mL of sterilized 50 186 
mM sodium citrate (Sigma-Aldrich, UK) solution (pH, 7.5) in a stomacher. Bacterial cells were 187 
separated and enumerated as reported by Prasanna and Charalampopoulos (2018).  188 
 189 
 Determination of pH of yoghurt during storage 190 
The pH changes of probiotic yoghurts were measured weekly during the storage period using 191 
a benchtop pH meter (Mettler Toledo, UK) as explained by Prasanna et al. (2013) and the 192 
measurements were taken at room temperature.    193 
 194 
 Scanning electron microscopic (SEM) analysis of cross sections of capsules 195 
Dehydration of capsules was carried out sequentially in a series of ethanol solutions (30, 50, 196 
70, 80, 90, and 100%). For this purpose, capsules were soaked for 15 min. in each solution. 197 
Thereafter, a critical point dryer (Balzers CPD 030, Liechtenstein, Germany) with liquid 198 
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carbon dioxide was used to dry capsules. Dried capsules were cut into two halves to obtain 199 
cross sections using a sterilized scalpel. Coating of samples and examination of samples using 200 
a scanning electron microscope (FEI, Quanta 600 F, USA) were carried out as described earlier 201 
(Prasanna and Charalampopoulos, 2018).           202 
 203 
 Statistical analysis 204 
The experiment was conducted in triplicate. One-way analysis of variance (ANOVA) with 205 
Turkey’s multiple comparison tests (SAS, version 9.2, SAS Institute Inc., Cary NC, USA) was 206 
used to analyse size and EY of capsules. Split-plot in time design using the General Linear 207 
Model (GLM) procedure of SAS was used to analyse results of viable count and pH of goat 208 
milk yoghurt (version 9.2, SAS Institute Inc., Cary NC, USA).    209 
 210 
3. Results and discussion 211 
 Size, EY and surface morphology of cross sections of capsules  212 
As shown in Table 1, mixing of inulin into alginate-goat milk based matrix significantly 213 
(p<0.05) increased the size of capsules compared to the control (0% inulin); more specifically, 214 
the capsule sizes increased as the inulin concentration increased. For example, capsule sizes 215 
were increased from 2.98 to 3.4 mm for 0.5% inulin and 2% inulin respectively. This may be 216 
due to changes in viscosity of five different matrices where a higher level of inulin 217 
concentration can lead for higher viscosity which can result in larger capsules as describe by 218 
Cheow et al. (2014). This observation is consistent with the findings of Chávarri et al. (2010) 219 
and Krasaekoopt and Watcharapoka (2014) who observed that prebiotic addition into alginate-220 
based material resulted in larger capsular size.  221 
 222 
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The results further revealed that the incorporation of inulin into alginate-goat milk based matrix 223 
had no significant (p>0.05) influence on the EY of capsules (Table 1).  Values of EY ranged 224 
from 87 – 91%. Moreover, this high encapsulation yield reveals that alginate-goat milk-inulin 225 
is a compatible matrix which can be used to encapsulate probiotics such as B. animalis subsp. 226 
lactis BB-12. Our results are consistent with findings of Shi et al. (2013) during the 227 
microencapsulation of probiotic Lactobacillus buguricus with alginate milk microsphere, 228 
where the EY values were around 100%. It was observed that the addition of prebiotics and 229 
milk proteins in the matrix can lead to higher EY (Soukoulis et al., 2014). In addition, the 230 
higher encapsulation yield may be due to the mild conditions such as room temperature (25 231 
C) with all natural substances which have a minimum detrimental effect on the 232 
microorganism.  233 
 234 
Cross sections of capsules are shown in Fig.1 and each type of matrix showed a distinctive 235 
morphology. The cross section of alginate-goat milk showed a porous structure Fig.1, (a). 236 
The addition of inulin into alginate-goat milk resulted in more compact capsules with less 237 
visible pores Fig.1, (b), (c), (d) and (e)]; the most densely packed capsules were observed with 238 
2% inulin Fig.1, (e). This may be due to the ability of inulin to make a compact network with 239 
proteins of alginate-goat milk matrix leading to densely packed capsules. In general, inulin is 240 
a water-soluble fibre and it was observed to form complexes with proteins of goat milk leading 241 
to a part of a strong structural network (Costa et al., 2015). Similarly, de Souza Oliveira et al. 242 
(2011) observed a reaction of inulin and dairy proteins leading for higher firmness of the 243 
mixture. The compact structure of capsules observed with the mixing of inulin to alginate-goat 244 
milk matrix is very important in food applications and during the digestion process since this 245 
can limit exposure of highly vulnerable probiotic bacteria to the harsh external environmental 246 
conditions. Furthermore, this property of new capsules may support to increase the survival of 247 
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bacteria in food products in the manufacturing process and storage of food items and to deliver 248 
the probiotic to the colon at a higher survival rate.     249 
 250 
 Performance of free and encapsulated bifidobacteria during sequential incubation in SGC 251 
Free and the encapsulated cells were exposed to in vitro SGC and the results are presented in 252 
Table 2. A continuous reduction of number of free probiotic cells was observed and the cell 253 
number dropped to a value which was undetectable (< 101 cfu mL-1) after the sequential 254 
exposure of free cells to SGJ (90 min) followed by SIJ (120 min).  255 
 256 
Encapsulation has been recommended to deliver viable cells to the gastro intestinal track 257 
(Champagne et al., 2018). Addition of inulin to alginate-goat milk matrix during encapsulation 258 
increased the resistance of the probiotic to the SGC, resulting in higher viable cell count than 259 
without inulin under all conditions. Similarly, supplement of inulin to alginate during 260 
encapsulation of  Lactobacillus acidophilus 5 and Lactobacillus casei 01 was observed to 261 
improve the survival of bacteria under SGC (Krasaekoopt and Watcharapoka, 2014). In 262 
addition, a higher survival rate of B. bifidum and B. longum encapsulated in alginate-263 
fructooligosaccharides under SGC was reported by Chen et al. (2005). In another study, spray 264 
drying was used to produce microcapsules containing B. bifidum BB-12 and the probiotic was 265 
observed to improve their survival under SGC (Verruck et al., 2017). Milk proteins have been 266 
characterized to have a good buffering capacity which can protect probiotics from the harsh 267 
environment which exists in the gastrointestinal tract (Anthony et al., 2015). Guérin et al. 268 
(2003) also described that milk-based proteins could improve survival of bifidobacteria 269 
capsulated in pectin, alginate and whey proteins than free bacteria under the SGC.  270 
 271 
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Furthermore, it was reported that milk fat can play a role in protecting probiotics from the 272 
acidic environment since fat can reduce diffusion of H+, organic acid and O2 (Picot and Lacroix, 273 
2004). As it was observed in this study using SEM micrographs Fig.1 (b), (c), (d) and (e), 274 
inulin modified the capsule structure by interacting with proteins leading a compact alginate-275 
goat milk matrix which may limit exposure of bacterial cells to the external environment and 276 
diffusion of chemical substances. Furthermore, the addition of inulin may improve the strength 277 
of the matrix and reduce the dissolution of capsules, consequently protecting the probiotic cells 278 
within the matrix.      279 
 280 
 Changes of survival rate of encapsulated and free bacterial cells in probiotic goat milk 281 
yoghurt at 4 C 282 
The changes in the viable count of encapsulated and free probiotic in probiotic goat milk 283 
yoghurts during the refrigerated storage for 28 d (Fig.2.). The results clearly revealed that there 284 
was a significant (p<0.05) loss of the viable count of free bacteria over a period of 28 d where 285 
there was 3.67 log cfu g-1 loss in viable counts of free bacterial cells during the storage period.  286 
Addition of inulin to the matrix led for better survival of probiotic bacteria in probiotic goat 287 
milk yoghurt; specially there was an increase of cell concentration in yoghurts when inulin 288 
concentration of capsules ranged from 0.5 to 2%. The cell concentration of yoghurt containing 289 
encapsulated probiotics did not decrease below the recommended level (106-107 cfu/mL or g) 290 
over 28 d of storage. The higher survival rate observed in inulin containing capsules in goat 291 
milk yoghurt may be due to the better protection provided by compact structure of alginate-292 
goat milk-inulin matrices observed in SEM micrographs Fig.1 (b), (c), (d) and (e). 293 
Furthermore, the higher viability of encapsulated bacteria in inulin-based matrices in the goat 294 
milk yoghurt, may be due to the limited potential of passing capsule wall by growth inhibiting 295 
substances which can be resulted during the fermentation process including acids and hydrogen 296 
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peroxide as reported by Krasaekoopt and Watcharapoka (2014). Furthermore, it was observed 297 
that capsules containing prebiotics could provide the carbon and nitrogen sources for 298 
encapsulated probiotics leading for higher survival rate of Bifidobacterium and Lactobacillus 299 
in milk (Chen et al., 2005). Similarly, other encapsulating materials such as alginate (Kebary 300 
and Hussein, 1999), alginate-starch (Adhikari et al., 2000) and -carrageenan were observed 301 
to improve survival of probiotic Bifidobacterium species in fermented dairy foods under 302 
refrigerated storage. Moreover, different prebiotics such as inulin (Akhiar and Aqilah, 2010), 303 
fructooligosaccharides  and raftilose (Iyer and Kailasapathy, 2005) with alginate-based 304 
capsules have been shown to be effective in improving probiotic viability in some dairy 305 
products. In addition, goat milk is considered as a suitable vehicle to deliver probiotic to 306 
humans. The properties of goat milk including appropriate pH, higher nutrient content and 307 
good buffering capacity lead for viability of probiotic during shelf life (Ranadheera et al., 308 
2018). Furthermore, the market share of functional yoghurt continues to grow and functional 309 
yoghurt containing probiotics, prebiotics and various plant extracts are being developed and 310 
introduced to satisfy consumer demand (Fazilah et al., 2018). Therefore, this new goat milk 311 
yoghurt containing a novel capsule containing probiotic may have a good market demand. 312 
     313 
3.4. pH Changes of probiotic goat milk yoghurt during storage 314 
Depending on the type of bacterial cells and the level of inulin supplementation during the 315 
encapsulation, the pH of goat milk yoghurt changed (Fig. 3). All goat milk yoghurt types 316 
showed a gradual decrease of pH during the storage period of 28 d. However, goat milk yoghurt 317 
containing free bacterial cells recorded the lowest pH value from 7th day to the end of the 318 
storage period. There were no significant differences (p>0.05) between final pH values of goat 319 
milk yoghurts produced with encapsulated bacterial cells. The decrease of pH of all types of 320 
goat milk yoghurt during storage is  mainly due to growth and metabolic activity of yoghurt 321 
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starter cultures which are reported to produce lactic acid at refrigerated storage (Shah et al., 322 
1995). In the case of goat milk yoghurt containing free bifidobacteria, in addition to yoghurt 323 
starter bacteria, cells of bifidobacteria are responsible acidifying goat milk yoghurt by 324 
producing both lactic and acetic acids and they have been reported to produce these acids with 325 
yoghurt starter cultures even at refrigerated storage (Samona et al., 1996). Similarly, a decrease 326 
in pH of cow milk yoghurt containing encapsulated B. lactis (Kailasapathy, 2006), B. breve 327 
R070 (Picot and Lacroix, 2004) and B. longum (Adhikari et al., 2003) was observed. The 328 
results of this study revealed that post-acidification in probiotic goat milk yoghurt produced 329 
with capsulated B. animalis subsp. lactis BB-12 was slower compared with probiotic goat milk 330 
yoghurt containing free bacterial cells. 331 
 332 
However, it is important to conduct a sensory evaluation to have a better understanding of the 333 
effect of this new capsule on the sensory properties of probiotic goat milk yoghurts. This new 334 
capsule may have the effect on sensory attributes of probiotic goat milk yoghurt such as 335 
appearance, aroma, flavour and texture which have been established with some other functional 336 
dairy products (Esmerino et al., 2017; Janiaski et al., 2018; Silva et al., 2018). Therefore, a 337 
sensory evaluation of the goat milk yoghurt containing the new capsule will be carried out to 338 
assess its consumers’ acceptability.      339 
 340 
4. Conclusions 341 
The present study showed that addition of inulin to alginate-goat milk during encapsulation 342 
increased the size of capsules while it had no effect on EY. SEM micrographs revealed that 343 
inulin could lead for compact interior structural characteristics. The addition of inulin to 344 
alginate-goat milk capsules led for a better protection to probiotic cells in simulated 345 
gastrointestinal condition. Inulin could improve the survival rate of capsulated probiotic cells 346 
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compared to capsules without inulin and free cells in probiotic goat milk yoghurt stored over 347 
28 d. A slower post-acidification of probiotic goat milk yoghurt was observed with 348 
encapsulated probiotic cells compared to that of free probiotic cells. The results revealed that 349 
addition of 1% inulin (w/v) to alginate-goat milk mixture could be used to improve the survival 350 
rate of B. animalis subsp. lactis BB-12 in probiotic goat milk yoghurt. Nevertheless, a sensory 351 
evaluation should be conducted to have a clear idea about how capsules effect on the sensory 352 
properties of probiotic goat milk yoghurt such as colour, texture, acidity and flavour.    353 
 354 
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Figure captions 543 
Fig.1. Scanning electron micrographs showing the cross section of different capsules. a: 544 
capsules were prepared using alginate and goat milk at a ratio of 1.5:1 (v/v). b: capsules were 545 
prepared using alginate and goat milk at a ratio of 1.5:1 (v/v) and inulin 0.5% (w/v). c: capsules 546 
were prepared using alginate and goat milk at a ratio of 1.5:1 (v/v) and inulin 1% (w/v). d: 547 
capsules were prepared using alginate and goat milk at a ratio of 1.5:1 (v/v) and inulin 1.5% 548 
(w/v). e: capsules were prepared using alginate and goat milk at a ratio of 1.5:1 (v/v) and inulin 549 
2% (w/v). (magnification 10,000×). White  shows the bacterial cells. 550 
 551 
Fig.2. Survival of free and encapsulated B. animalis subsp. lactis BB-12 in goat milk yoghurt 552 
at 4 C for 28 days. Vertical lines represent standard deviations. ABCMeans with different 553 
uppercase are significantly different (p<0.05) between each time, for each type of alginate-554 
goat milk capsule during the storage. abcdMeans with different lowercase are significantly 555 
different (p<0.05) between each type of alginate-goat milk capsule, for a particular day of the 556 
storage period. Free: Free bacterial cells. 0%: capsules were prepared using alginate and goat 557 
milk at a ratio of 1.5:1 (v/v). 0.5: capsules were prepared using alginate and goat milk at a ratio 558 
of 1.5:1 (v/v) and inulin 0.5% (w/v). 1: capsules were prepared using alginate and goat milk at 559 
a ratio of 1.5:1 (v/v) and inulin 1% (w/v). 1.5: capsules were prepared using alginate and goat 560 
milk at a ratio of 1.5:1 (v/v) and inulin 1.5% (w/v). 2: capsules were prepared using alginate 561 
and goat milk at a ratio of 1.5:1 (v/v) and inulin 2% (w/v). Free: Free cells. 562 
 563 
Fig.3. Changes in pH of goat milk yoghurt containing free and encapsulated bacterial cells at 564 
4 C for 28 days. Vertical lines represent standard deviations. ABCDEMeans with different 565 
uppercase are significantly different (p<0.05) between each time, for each type of alginate-566 
goat milk based capsule during the storage. abcdefMeans with different lowercase are 567 
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significantly different (p<0.05) between each type of alginate-goat milk based capsule, for a 568 
particular day of the storage period. For legend explanations see Fig. 2. 569 
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Tables 593 
Table 1. Influence of different concentrations of inulin on the size and encapsulation yield of 594 
different capsules   595 
Concentration of inulin (% w/v) Size of capsules (mm) Encapsulation yield (%) 
0 2.79 ± 0.33b 90.84 ± 3.10a 
0.5 2.98 ± 0.23ab 91.67 ± 1.76a 
1 3.11 ± 0.58ab 91.94 ± 3.88a 
1.5 
2 
3.32 ± 0.35a 
3.41 ± 0.44a 
90.57 ± 2.04a 
87.45 ± 2.06a 
abMean values (±standard deviation) within the same column not sharing a common superscript 596 
differ significantly (P < 0.05).  597 
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 602 
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 609 
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Table 2. Survival of free and encapsulated B. animalis subsp. lactis BB-12 after incubation in 612 
simulated gastric juice (pH 2) at 37 C for 30, 60, 90 and 120 min and in simulated intestinal 613 
juice pH (7.5) at 37 C for 2h (Value represents both after gastric and intestinal digestion in 614 
vitro)  615 
Type of cells Concentr
ation of 
inulin 
(%) 
Number of viable cells (log cfu mL-1/ log cfu g-1) 
0 30 60 90 120 
Free   9.43 ± 0.08A a 7.37 ± 0.32B b 3.49 ± 0.09C c ND ND 
Encapsulated 0  9.49 ± 0.12A a 8.22 ± 0.10B b 8.11 ± 0.11B b 8.09 ± 0.09B b 8.07 ± 0.03B b 
 0.5  9.47 ± 0.11A a 8.28 ± 0.26B ab 8.21 ± 0.21B ab 8.14 ± 0.12B b 8.11 ± 0.18B b 
 1  9.45 ± 0.23A a 8.38 ± 0.07B ab 8.33 ± 0.05B ab 8.28 ± 0.18B a 8.14 ± 0.11B a 
 1.5  9.45 ± 0.14A a 8.62 ± 0.16B ab 8.52 ± 0.18BC a 8.43 ± 0.07C a 8.41 ± 0.19C a 
 2  9.44 ± 0.11A a 8.70 ± 0.22B a 8.54 ± 0.06BC a 8.46 ± 0.15C a 8.44 ± 0.10C a 
ABCDMeans in the same row without common letter differ significantly (p<0.05) for each type 616 
of capsules. abcdeMeans in the same column for each type of capsule without common letter 617 
differ significantly (p<0.05) for a particular time. Data are expressed as mean ± standard 618 
deviation. ND: Not detected. 619 
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